U.S. SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 12b-25
SEC FILE NUMBER
0-27937
NOTIFICATION OF LATE FILING CUSIP NUMBER
2614X 100
(Check One:)
|X| Form 10-K and 10-KSB |_| Form 20-F |_| Form 11-K |_| Form 10-Q and 10-QSB
|_| Form N-SAR
For Period Ended: December 31, 1999
-----------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:
Read the attached instruction sheet before preparing form. Please
print or type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
- -------------------------------------------------------------------------------
PART I -- REGISTRANT INFORMATION
- -------------------------------------------------------------------------------
Full Name of Registrant
DRAGON PHARMACEUTICAL INC.
- -------------------------------------------------------------------------------
Former Name if Applicable
FIRST GENEVA INVESTMENTS, INC.
- -------------------------------------------------------------------------------
Address of Principal Executive Office (Street and Number)
543 GRANVILLE STREET, SUITE 1200
- -------------------------------------------------------------------------------
City, State and Zip Code
VANCOUVER, BRITISH COLUMBIA V6C 1X8
- -------------------------------------------------------------------------------
PART II -- RULES 12b - 25(b) and (c)
- -------------------------------------------------------------------------------
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate.)
|X| (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
|X| (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-K, Form 11-K, Form N-SAR or a
portion thereof will be filed on or before the fifteenth calendar
day following the prescribed due date; or the subject quarterly
report or transition report on Form 10-Q or portion thereof will
be filed on or before the fifth calendar day following the
prescribed due date; and
|X| (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
<PAGE>2
- -----------------------------------------------------------------------------
PART III -- NARRATIVE
- ------------------------------------------------------------------------------
State below in reasonable detail the reasons why Form 10-K and 10-KSB, 20-F,
11-K, 10-Q and 10-QSB, N- SAR, or the transition report or portion thereof could
not be filed within the prescribed period.
THE COMPANY REQURIES ADDITIONAL TIME TO REVIEW AND COMPLETE THE FORM 10-KSB.
- ------------------------------------------------------------------------------
PART IV -- OTHER INFORMATION
- -------------------------------------------------------------------------------
(1) Name and telephone number of person to contact in regard to this
notification.
SHAUN MASKERINE 604 669-8817
- ------------------- ------------- --------------------
(Name) (Area Code) (Telephone Number)
(2) Have all other periodic reports required under section 13 or 15(d)
of the Securities Exchange Act of 1934 or section 30 of the Investment Company
Act of 1940 during the preceding 12 months or for such shorter period that the
registrant was required to file such report(s) been filed? If the answer is no,
identify report(s).
|X| Yes |_| No
(3) Is it anticipated that any significant change in results of
operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or
portion thereof?
|_| Yes |X| No
DRAGON PHARMACEUTICAL INC.
-----------------------------------------------
(Name of Registrant as specified in charter)
has caused this notification to be signed on its behalf by the undersigned
thereunto duly authorized.
Date: MARCH 28, 2000 By: /s/ SHAUN MASKERINE
---------------- ------------------
Shaun Maskerine
